GPX Medical
Every day, one in ten babies are born preterm, many of them with underdeveloped lungs that can advance to life-threatening conditions during their stay in the hospital and risk disabilities later on in life. They deserve a better start in life and health care professionals need support of modern technology to make life-changing decisions that can improve the health of these fragile patients.
GPX Medical’s groundbreaking innovation NEOLA® will upgrade today’s neonatal intensive care to include continuous lung monitoring and real-time alerts of life-threatening complications.
We are on a journey to revolutionize neonatal intensive care
Lung monitoring with NEOLA
GPX Medicals’ proven technology uses laser spectroscopy to continuously measure lung volume changes and oxygen gas concentration in the lungs of preterm born infants. This is a safe and non-invasive method to monitor the lungs of these vulnerable patients in real time, providing the possibility of instant detection and treatment of complications and thus improving the care and decreasing the risk of disabilities later in life.
Latest News from GPX Medical
GPX Medical erhåller patent i Kina vilket öppnar upp möjligheter för lungövervakning av fler patientgrupper
GPX Medical AB (publ) meddelar idag att bolaget har beviljats ett nytt...
VD Hanna Sjöström medverkade i “Life Science branschens tillväxt- och finansieringsmöjligheter i pandemins kölvatten”
GPX Medicals VD Hanna Sjöström medverkade den 7 juli i seminariet "Life...
GPX Medical lämnar pre-submission till FDA för NEOLA®
GPX Medical AB (publ) meddelar att bolaget har lämnat in en så kallad...
For Investors
We are on a journey to revolutionize neonatal intensive care
Learn more about investing in GPX Medical
